Skip to main content
. 2023 Jul 10;42:e2022106. doi: 10.1590/1984-0462/2024/42/2022106

Table 1. Characteristics of the population before and after the implementation of the Koala Project.

Group p-value
Before After
Hospital n (%)
1 24 (41.4) 21 (50) 0.421F
2 34 (58.6) 21 (50)
Sex n (%)
Female 21 (36.2) 23 (54.8) 0.071F
Male 37 (63.8) 19 (45.2)
Gestational age (weeks) - median (IQR) 33 (31-35) 32 (30-33) 0.108M
Gestational age (weeks) - n (%)
<28 4 (6.9) 6 (14.3) 0.137Q
28–31 18 (31) 12 (28.6)
32–33 13 (22.4) 15 (35.7)
34–36 23 (39.7) 9 (21.4)
Types of delivery - n (%)
Vaginal 29 (50) 20 (47.6) 0.842F
C-Section 29 (50) 22 (52.4)
Maternal urinary infection - n (%) 12 (20.7) 7 (18.9) 1.000F
Chorioamnionitis - n (%) 5 (8.6) 0 (0) 0.075F
Rupture of membranes - n (%) 12 (20.7) 7 (17.1) 0.797F
Diabetes mellitus - n (%) 1 (1.7) 0 (0) 1.000F
Gestational diabetes - n (%) 3 (5.2) 1 (2.4) 0.640F
Gestational hypertension - n (%) 9 (15.5) 7 (17.1) 1.000F
HEELP syndrome - n (%) 2 (3.4) 2 (4.9) 1.000F
Preeclampsia - n (%) 4 (6.9) 0 (0) 0.140F
Septic shock. - n (%) 9 (15.5) 5 (11.9) 0.772F
Respiratory distress syndrome - n (%) 28 (48.3) 29 (74.4) 0.012F
Pneumonia - n (%) 4 (6.9) 3 (7.1) 1.000F
Transient tachypnea of newborn - n (%) 21 (36.2) 11 (26.2) 0.386F
Bronchopneumonia - n (%) 9 (15.5) 1 (2.4) 0.042F
Early neonatal infection - n (%) 40 (69) 31 (73.8) 0.660F
Early onset sepsis - n (%) 9 (15.5) 20 (47.6) 0.001F
Late onset sepsis - n (%) 2 (3.4) 4 (9.5) 0.235F
Neonatal jaundice - n (%) 45 (77.6) 31 (73.8) 0.813F
COVID 19 - n (%) 1 (1.7) 5 (12.2) 0.079F
% of SpO2 records
<91% - median (IIQ) 1.9 (0–4.5) 4 (1.5–9.7) 0.008M
>95% - median (IIQ) 83.3 (70.4–93.5) 73.1 (56.2–87) 0.008M
<91% and SpO2>95% - median (IIQ) 87 (73.9–94.4) 76.6 (65.7–88.5) 0.010M
91% ≤SpO2 ≤95% - median (IIQ) 13 (5.6–26.1) 23.4 (11.5–34.3) 0.010M

n: absolute frequency; %: relative frequency percentage; IQR: Interquartile Range; F: Fisher Exact Test; M: Mann-Whitney Test; Q: Pearson’s Chi-Square Test; SpO2: pulse oximeter oxygen saturation.